Entheon Biomedical Corp. (CSE:ENBI)

Canada flag Canada · Delayed Price · Currency is CAD
0.1200
+0.0200 (20.00%)
Jul 18, 2025, 3:56 PM EDT
60.00%
Market Cap1.66M
Revenue (ttm)n/a
Net Income (ttm)-360.40K
Shares Out13.86M
EPS (ttm)-0.03
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume21,500
Average Volume12,624
Open0.1100
Previous Close0.1000
Day's Range0.1100 - 0.1200
52-Week Range0.0750 - 0.4500
Beta1.56
RSI71.98
Earnings DateJun 30, 2025

About Entheon Biomedical

Entheon Biomedical Corp. operates as a biotechnology research and development company. The company develops products for treating addiction and substance use disorders. Entheon Biomedical Corp. is headquartered in Vancouver, Canada. [Read more]

Industry Biotechnology
Sector Healthcare
CEO Timothy Ko
Employees 1
Stock Exchange Canadian Securities Exchange
Ticker Symbol ENBI
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.